Canada markets closed

Algernon Pharmaceuticals Inc. (AGN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.11000.0000 (0.00%)
At close: 11:01AM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-08-31
2022-08-31
2021-08-31
2020-08-31
Cash flows from operating activities
Net Income
-5,423
-6,781
-6,054
-7,734
-8,538
Depreciation & amortization
46.135
50.398
34.936
0
0
Stock based compensation
729.055
1,257
530.835
827.402
3,179
Change in working capital
1,208
1,266
2,584
-597.874
-1,069
Accounts receivable
196.089
567.802
1,614
-1,151
-
Other working capital
-1,840
-2,613
-3,057
-7,947
-6,710
Other non-cash items
-
40
-
-305.117
-
Net cash provided by operating activites
-1,798
-2,553
-2,913
-7,823
-6,610
Cash flows from investing activities
Investments in property, plant and equipment
-
-59.5
-144.608
-124.448
-99.741
Net cash used for investing activites
-41.764
-59.5
-144.608
-124.448
-99.741
Cash flows from financing activities
Common stock issued
-
1,226
2,055
2,694
9,259
Other financing activites
-
-
-
-311.67
-
Net cash used privided by (used for) financing activities
1,226
1,329
2,055
4,245
12,620
Net change in cash
-615.533
-1,283
-1,003
-3,710
5,914
Cash at beginning of period
689.699
1,409
2,411
6,121
207.812
Cash at end of period
75.802
125.085
1,409
2,411
6,121
Free Cash Flow
Operating Cash Flow
-1,798
-2,553
-2,913
-7,823
-6,610
Capital Expenditure
-
-59.5
-144.608
-124.448
-99.741
Free Cash Flow
-1,840
-2,613
-3,057
-7,947
-6,710